181 related articles for article (PubMed ID: 10548499)
1. The effect of AMP-activated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells.
Dagher Z; Ruderman N; Tornheim K; Ido Y
Biochem Biophys Res Commun; 1999 Nov; 265(1):112-5. PubMed ID: 10548499
[TBL] [Abstract][Full Text] [Related]
2. AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low-intensity muscle contraction.
Raney MA; Yee AJ; Todd MK; Turcotte LP
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E592-8. PubMed ID: 15547141
[TBL] [Abstract][Full Text] [Related]
3. Acute regulation of fatty acid oxidation and amp-activated protein kinase in human umbilical vein endothelial cells.
Dagher Z; Ruderman N; Tornheim K; Ido Y
Circ Res; 2001 Jun; 88(12):1276-82. PubMed ID: 11420304
[TBL] [Abstract][Full Text] [Related]
4. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
5. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes.
Sakoda H; Ogihara T; Anai M; Fujishiro M; Ono H; Onishi Y; Katagiri H; Abe M; Fukushima Y; Shojima N; Inukai K; Kikuchi M; Oka Y; Asano T
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1239-44. PubMed ID: 12006353
[TBL] [Abstract][Full Text] [Related]
6. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328
[TBL] [Abstract][Full Text] [Related]
7. Prior serum- and AICAR-induced AMPK activation in primary human myocytes does not lead to subsequent increase in insulin-stimulated glucose uptake.
Al-Khalili L; Krook A; Zierath JR; Cartee GD
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E553-7. PubMed ID: 15149951
[TBL] [Abstract][Full Text] [Related]
8. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle.
Li J; Hu X; Selvakumar P; Russell RR; Cushman SW; Holman GD; Young LH
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E834-41. PubMed ID: 15265762
[TBL] [Abstract][Full Text] [Related]
9. AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo.
Shearer J; Fueger PT; Rottman JN; Bracy DP; Martin PH; Wasserman DH
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E871-7. PubMed ID: 15265760
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin-mediated stimulation of AMP-activated protein kinase (AMPK) in pancreatic beta cells.
Huypens P; Moens K; Heimberg H; Ling Z; Pipeleers D; Van de Casteele M
Life Sci; 2005 Jul; 77(11):1273-82. PubMed ID: 15893773
[TBL] [Abstract][Full Text] [Related]
11. AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells.
Cacicedo JM; Yagihashi N; Keaney JF; Ruderman NB; Ido Y
Biochem Biophys Res Commun; 2004 Nov; 324(4):1204-9. PubMed ID: 15504342
[TBL] [Abstract][Full Text] [Related]
12. AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms.
Xiang X; Saha AK; Wen R; Ruderman NB; Luo Z
Biochem Biophys Res Commun; 2004 Aug; 321(1):161-7. PubMed ID: 15358229
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport.
Abbud W; Habinowski S; Zhang JZ; Kendrew J; Elkairi FS; Kemp BE; Witters LA; Ismail-Beigi F
Arch Biochem Biophys; 2000 Aug; 380(2):347-52. PubMed ID: 10933890
[TBL] [Abstract][Full Text] [Related]
14. The effect of AMP-activated kinase activation on gonadotrophin-releasing hormone secretion in GT1-7 cells and its potential role in hypothalamic regulation of the oestrous cyclicity in rats.
Coyral-Castel S; Tosca L; Ferreira G; Jeanpierre E; Rame C; Lomet D; Caraty A; Monget P; Chabrolle C; Dupont J
J Neuroendocrinol; 2008 Mar; 20(3):335-46. PubMed ID: 18194429
[TBL] [Abstract][Full Text] [Related]
15. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
Velasco G; Geelen MJ; Guzmán M
Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
[TBL] [Abstract][Full Text] [Related]
16. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin.
Camacho RC; Lacy DB; James FD; Donahue EP; Wasserman DH
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1039-43. PubMed ID: 16046457
[TBL] [Abstract][Full Text] [Related]
17. Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes.
Musi N; Goodyear LJ
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):119-27. PubMed ID: 12476786
[TBL] [Abstract][Full Text] [Related]
18. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes.
Yamaguchi S; Katahira H; Ozawa S; Nakamichi Y; Tanaka T; Shimoyama T; Takahashi K; Yoshimoto K; Imaizumi MO; Nagamatsu S; Ishida H
Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E643-9. PubMed ID: 15928020
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone treatment enhances acute AMP-activated protein kinase-mediated muscle and adipose tissue glucose uptake in high-fat-fed rats.
Ye JM; Dzamko N; Hoy AJ; Iglesias MA; Kemp B; Kraegen E
Diabetes; 2006 Oct; 55(10):2797-804. PubMed ID: 17003345
[TBL] [Abstract][Full Text] [Related]
20. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
